In an RCT that included 40 patients that compared the glycemic control effects of gastric cancer surgery according to surgery type, patients who experienced improvement or remission of diabetes at 12 months after surgery had higher preoperative leptin levels than those who did not [15]. The gene discussed is LEP; the disease is diabetes mellitus.